CUE vs EIX
Cue Biopharma (CUE) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
CUE currently screens at market cap $59.5M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the CUE and EIX stock pages for the full models.
Not investment advice.